您的购物车当前为空
别名 BMS-182874, BMS182874
BMS 182874 是一种口服有效的高选择性内皮素受体 endothelin receptor ETA 拮抗剂,对 ETA 的 IC50 值为0.150 μM,对 ETA 的 Ki 值为0.055 μM。BMS 182874 能够在大鼠高血压模型中降低 Deoxycorticosterone acetate 诱导的动脉压,可用于研究心血管疾病。

BMS 182874 是一种口服有效的高选择性内皮素受体 endothelin receptor ETA 拮抗剂,对 ETA 的 IC50 值为0.150 μM,对 ETA 的 Ki 值为0.055 μM。BMS 182874 能够在大鼠高血压模型中降低 Deoxycorticosterone acetate 诱导的动脉压,可用于研究心血管疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 200 | In stock | |
| 5 mg | ¥ 487 | In stock | |
| 10 mg | ¥ 777 | In stock | |
| 25 mg | ¥ 1,330 | In stock | |
| 50 mg | ¥ 1,910 | In stock | |
| 100 mg | ¥ 2,670 | In stock | |
| 200 mg | ¥ 3,630 | In stock |
BMS 182874 相关产品
| 产品描述 | BMS 182874 is an orally effective and highly selective endothelin receptor ETA antagonist with an IC50 value of 0.150 μM for ETA and a Ki value of 0.055 μM for ETA.BMS 182874 is able to reduce arterial pressure in a rat hypertension model induced by Deoxycorticosterone acetate. BMS 182874 was able to reduce Deoxycorticosterone-induced arterial pressure in a rat model of hypertension and can be used to study cardiovascular disease. |
| 靶点活性 | ETA:0.150 μM, ETA:0.055 μM(Ki ) |
| 体外活性 | BMS-182874(dimethyla minonalogue 11)是一种有效的ETA诱导的细胞内Ca2+增加的功能性拮抗剂,在vs-A10细胞中的IC50值为0.150 μM。Ki值为0.055 μM。在兔颈动脉环中的KB值为0.520 μM/[1]。 |
| 体内活性 | BMS 182874 (100 μM/kg; 单次口服) 使动脉血压从对照水平缓慢下降25%。在给药后12小时和24小时,动脉血压维持在比对照水平低12%。[1] |
| 别名 | BMS-182874, BMS182874 |
| 分子量 | 345.42 |
| 分子式 | C17H19N3O3S |
| CAS No. | 153042-42-3 |
| Smiles | S(NC1=C(C)C(C)=NO1)(=O)(=O)C=2C3=C(C(N(C)C)=CC=C3)C=CC2 |
| 密度 | 1.332g/cm3 |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 55 mg/mL (159.23 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容